Olympia– Washington state will keep a little portion of a $280 million nationwide settlement including a pharmaceutical company implicated of dedicating scams by promoting 2 drugs for unapproved cancer treatments.
Celgene Corp. rejected misdeed but accepted pay the federal government, 28 states and the District of Columbia to settle a whistleblower claim brought by a previous company saleswoman. Washington state will keep about $368,000 for its Medicaid program under the settlement revealed Tuesday. The whistleblower might be entitled to as much as $84 million.
Washington Attorney General Bob Ferguson states that from 2000 to 2015, Celgene marketed and offered medications Revlimid and Thalomid for conditions the FDA had not authorized, which the company promoted the drugs by making incorrect or deceptive declarations in medical literature and scientific research studies.
District attorneys likewise stated Celgene paid doctors kickbacks for recommending the medications.